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Epidemiologic studies suggest that particulate
matter (PM) air pollution may enhance
symptom severity and frequency in allergic
asthmatics. There is also evidence that air pol-
lution is associated with an increase in hospi-
tal emergency room visits for asthma (Lipsett
et al. 1997; Schwartz et al. 1993). Although
the epidemiologic evidence is consistent, the
mechanisms by which air pollution increase
asthmatic symptoms remains unclear.
Animal studies have shown enhanced
allergic sensitization by combustion particles
(Hamada et al. 2000; Lambert et al. 2000), as
well as a greater-than-additive interaction
between combustion particles and allergic
response to ovalbumin (Gavett et al. 1999;
Kobayashi et al. 2000). There is also evidence
that exposure to ambient pollutants enhances
the allergic response to allergen challenge in
humans. Experimental human studies have
shown that exposure to ozone (Jorres et al.
1996; Molﬁno et al. 1991; Peden et al. 1995)
and nitrogen dioxide alone (Devalia et al.
1994; Strand et al. 1997, 1998; Tunnicliffe et
al. 1994) or with sulfur dioxide (Rusznak et
al. 1996) enhance the allergic response. In
addition, there is also limited human evi-
dence demonstrating that particulate expo-
sure (e.g., diesel exhaust) may enhance the
allergic response (Diaz-Sanchez et al. 1997;
Takenaka et al. 1995).
To examine the relationship between com-
bustion particulate exposure and enhanced
inflammatory responses in humans, we con-
ducted an experimental study with fuel-oil
combustion particulates and pollen grains. To
simulate real-life exposure, we developed a
system whereby we could challenge the sub-
ject with aerosolized whole pollen grains
rather than using allergen extracts as in earlier
human experimental exposure studies.
We chose the upper airway as a model of
allergic inflammation and nasal lavage (NL)
as a noninvasive method for obtaining sam-
ples. The nasal cavity is an excellent model of
allergic inflammation and provides an easily
accessible site for study. There is sufficient
evidence that NL can be successfully used to
investigate the inﬂammatory response in the
nasal cavity (Bascom et al. 1989; Castells and
Schwartz 1988; Durham et al. 1992; Lebel et
al. 1988; Skoner et al. 1990; Togias et al.
1988).
Methods
Subjects. The study included atopic subjects
with and nonatopic subjects without self-
reported seasonal allergic rhinitis. All subjects
signed a consent form approved by the
Harvard School of Public Health Human
Subjects Committee. Subject exclusion crite-
ria included asthma or a history of asthma,
current (within the last year) smokers,
immunotherapy (to any allergen/antigen) in
the previous 3 years, nasal abnormalities such
as nasal septal deviations or polyps, perennial
rhinitis, or any acute or chronic condition or
disease for 3 months before the study. All
subjects were screened for and had normal
pulmonary function.
Subjects with a respiratory tract infection
were not studied until the acute event had
clinically resolved and at least 3 weeks had
elapsed. At least 4 weeks before and during
the study session, subjects were asked not to
use H1 histamine-receptor antagonists, nasal
beclomethasone (and other nasal steroids),
nasal or inhaled cromoglycate, and oral or
inhaled steroids. They refrained from using
aspirin, nonsteroidal anti-inflammatory
agents, and vitamin C and E supplements for
10 days before and during the study sessions.
For 6 hr before the exposure session, subjects
did not have caffeinated medications or bev-
erages. Subjects were instructed not to engage
in moderate to heavy physical exertion at least
4 hr before the exposure session and during
the day of the exposure session.
Skin prick test. We conducted skin prick
tests using six common inhalant allergens
(Dermatophagoides pteronyssinus, mixed
grasses, ragweed, birch tree, oak tree, and
Alternaria) and positive and negative controls
(histamine and saline, respectively). A positive
test was recorded if the maximum wheal
diameter was 3 mm larger than the saline
control. Subjects were deﬁned as atopic if one
or more skin tests were positive. We used the
results of the skin prick test to determine the
aeroallergen used for the challenge.
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Although human experimental studies have shown that gaseous pollutants enhance the inﬂamma-
tory response to allergens, human data on whether combustion particulates enhance the inﬂam-
matory response to allergen are limited. Therefore, we conducted a human experimental study to
investigate whether combustion particulates enhance the inﬂammatory response to aeroallergens.
“Enhancement” refers to a greater-than-additive response when combustion particulates are deliv-
ered with allergen, compared with the responses when particulates and allergen are delivered
alone. Eight subjects, ﬁve atopic and three nonatopic, participated in three randomized exposure-
challenge sessions at least 2 weeks apart (i.e., clean air followed by allergen, particles followed by
no allergen, or particles followed by allergen). Each session consisted of nasal exposure to combus-
tion particles (target concentration of 1.0 mg/m3) or clean air for 1 hr, followed 3 hr later by chal-
lenge with whole pollen grains or placebo. Nasal lavage was performed immediately before particle
or clean air exposure, immediately after exposure, and 4, 18 and 42 hr after pollen challenge. Cell
counts, differentials, and measurement of cytokines were performed on each nasal lavage. In
atopic but not in nonatopic subjects, when allergen was preceded by particulates, there was a sig-
nificant enhancement immediately after pollen challenge in nasal lavage leukocytes and neu-
trophils (29.7 × 103 cells/mL and 25.4 × 103 cells/mL, respectively). This represents a 143% and
130% enhancement, respectively. The enhanced response for interleukin-4 was 3.23 pg/mL (p =
0.06), a 395% enhancement. In atopic subjects there was evidence of an enhanced response when
particulates, as compared to clean air, preceded the allergen challenge. Key words: allergy, atopy,
cytokines, inflammatory cells, particulates. Environ Health Perspect 111:472–477 (2003).
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challenge sessions were performed during the
winter months and therefore out of season for
pollens. To familiarize themselves with the
breathing apparatus and the NL procedure,
each subject participated in a training session
at least 2 weeks before the first session. The
order of the three sessions was single-blind,
randomized, and each session was separated
by at least 2 weeks. The three sessions con-
sisted of a) residual oil fly ash particulate
exposure followed by no allergen challenge,
referred to as session A (SA), b) clean air expo-
sure followed by allergen challenge, referred
to as session B (SB), and c) particulate expo-
sure followed by allergen challenge, referred
to as session C (SC).
On the day of each session, the subject
reported to the laboratory between 0800 and
1000 hr for a 1-hr particulate or clean air
exposure while seated at rest. After exposure,
the subject was free to leave the lab but was
instructed not to exercise or to leave the
building. Three hours after the particulate
exposure the subject was challenged with an
allergen or a placebo.
Particulate exposure. A bulk source of
residual oil fly ash (ROFA) from a Boston
power plant was resuspended using a Wright
Dust Feed Aerosol Generator (Model MK-II;
L. Adams Ltd., London, UK). The ROFA
was delivered using a disposable nasal mask
(Respironics, Inc., Murrysville, PA). The air
stream, containing particles, was divided into
two streams: 4 L/min was passed through 
a Harvard Marple Impactor (Harvard
Instruments, Boston, MA) to eliminate parti-
cles > 2.5 µm, and the rest of the air stream
was passed through a 0.2-µm ﬁlter. The out-
put from the Harvard impactor was iso-
kinetically fed into the nasal mask. Particle
size, composition, and airborne concentration
were measured during the exposures. We
determined concentration gravimetrically
using 0.2-µm Millipore ﬁlters and by contin-
uous monitoring with a real-time Aerosol
Monitor (Model RAS-1; MIE Inc., Bedford,
MA). The size distributions were determined
with an Aerosizer (Model MACCII; API Inc.,
Amherst, MA).
Allergen (whole pollen grain) challenge.
Pollen grains were aerosolized using a vibrat-
ing drum apparatus developed in our labora-
tory. The equipment consisted of an acoustic
speaker to generate acoustic waves. On top of
the speaker, a 15-inch long by 5-inch diame-
ter Plexiglas tube was placed. Both ends of the
Plexiglas tube were ﬁtted with dental rubber
dams to form a drumlike cover. The Plexiglas
tube has 0.5-inch ﬁttings on the bottom and
top. The top ﬁtting was connected to a pump
pulling approximately 30 lpm of room air.
The subject’s breathing mask was connected
between the Plexiglas tube and the pump.
The subject breathed through the mask for 30
sec during the aerosolization of the pollen. To
aerosolize the pollen, a bolus of pollen was
injected into the Plexiglas drum through the
bottom ﬁtting using a 1 cc tuberculin syringe.
The syringe was ﬁlled with 0.5 cc pollen (dry
allergen source material; Hollister Stier
Laboratories LLC, Spokane, WA) for each
allergen challenge. The subject was instructed
to perform slow shallow inspirations through
the nose during the pollen delivery phase.
The no allergen (placebo) challenge session
consisted of filling a 1 cc tuberculin syringe
(identical to the type used for allergen chal-
lenge) with air and introducing the air into
the allergen delivery drum. Because of the
design of the challenge apparatus, the subjects
could not see the syringe and were therefore
blinded as to whether they were receiving
allergen or placebo.
We monitored the pollen aerosol count
using the aerosizer (Model LD; Amherst
Process Instruments Inc., TSI, Amherst,
MA), which measures particles in the size
range of 0.12–200 µm. The atopic subjects
were challenged with either ragweed or tree
pollen based on whether they tested positive
for them on the skin prick test, while the
nonatopic subjects were challenged with red
oak. We chose ragweed and tree pollen
because they were reliably delivered using our
whole-grain pollen aerosol technique.
NL protocol. At the beginning of each
exposure-challenge session, two sequential NLs,
5 min apart, were performed. We used the
second lavage as the baseline NL (NLbaseline).
Nasal lavage was again performed immediately
(NLIA), 4 hr (NL4), 18 hr (NL18), and 42 hr
(NL42) after allergen challenge. The subject
tilted his or her head backward while a soft-
plastic catheter tip was inserted into one nos-
tril. A 10-mL syringe, attached to the catheter,
was used to instill 5 mL of warm (37°C), ster-
ile, Dulbecco’s phosphate-buffered saline
(PBS) solution (Sigma Chemical Co., St.
Louis, MO). The procedure was repeated on
the other nostril. N-acetyl cysteine (Sigma) was
added to the recovered NL ﬂuid to a ﬁnal con-
centration of 1 mM, and the sample was incu-
bated for 15 min at 37°C. The N-acetyl
cysteine was added to dissolve mucous. The
sample was then centrifuged at 915 × g at 4°C
for 10 min. The cell pellet was resuspended in
PBS, and total leukocytes were determined by
hemocytometer counts. We determined differ-
ential cell counts from modified Wright-
Giemsa-stained cytocentrifuge preparations.
Nasal lavage cell counts were expressed as cells
per milliliter, and differential cell counts were
expressed as percent cell type.
Immunoassays for proteins and cytokines.
We measured cytokine levels in NL ﬂuid using
commercial ELISA kits with chemiluminescent
detection (R&D Systems, Minneapolis, MN).
We measured interleukin (IL)-3, IL-4, IL-5,
IL-8, IL-13, tumor necrosis factor (TNF)-α,
monocyte chemotactic protein (MCP)-1, and
granulocyte macrophage-colony stimulating
factor (GM-CSF). Albumin was measured by
nepholometery (BN100, Dade-Behring,
Deerﬁeld, MI) using a low albumin protocol
recommended by the manufacturer. We mea-
sured total IgE, eosinophil cationic protein
(ECP) and tryptase using a commercial
immunoﬂuorometric instrument (AutoCAP;
Pharmacia and Upjohn, Kalamazoo, MI) and
using kits supplied by the same company.
Symptom questionnaire. Immediately
before exposure, immediately after, and 4 and
18 hr after allergen challenge the subject com-
pleted a questionnaire on nasal, ocular, and
upper and lower respiratory symptoms.
Statistical analysis. An enhanced inﬂam-
matory response was defined as a greater-
than-additive response when combustion
particulates were delivered with allergen, as
compared to the sum of the responses when
particulates and allergen were delivered alone.
More specifically, an enhanced response
occurred when the inﬂammatory response in
the particulate exposure-allergen challenge
session (SC) exceeded the sum of the
responses in the sessions to particulates alone
(SA) and allergen alone (SB). We deﬁned the
inﬂammatory response in each session as the
difference between the baseline level of cells
or cytokines and their level at time t after the
allergen challenge. Time t was either immedi-
ately after, 4 hr, 18 hr, or 42 hr after allergen
challenge. Mathematically the inflammatory
response for person i at time t after exposure-
challenge is ∆it = (NLit– NLibaseline), where
NLit = cell count or cytokine level at time t
for person i, NLibaseline = cell count or
cytokine level at baseline for person i. For
each of the three sessions, for each person i at
time t we calculated a ∆it. The ∆it for person i
at time t for SA is referred to as A_ ∆it, for SB
as B_ ∆it, and for SC as C_ ∆it. When C_ ∆it
exceeded the sum of A_ ∆it and B_ ∆it, a
greater-than-additive response occurred in
person i at time t. The magnitude of the
enhanced response in person i at time t is
referred to as E∆it, where E∆it = [C_ ∆it – {A_
∆it + B_ ∆it}]. At each time t, a we used
Wilcoxon signed-ranks test to determine
whether the distribution of the E∆it values
was zero (null hypothesis); if they were not
different from zero, this was evidence that
there was no enhancement of the inflamma-
tory response. The alternative hypothesis was
that the E∆it values have a positive central
location; if the E∆it values have a positive cen-
tral location, this was evidence that particu-
lates enhanced the response to pollen. We
used the Wilcoxon signed-ranks test because
the E∆it values were not normally distributed.
A one-sided test was used because a priori we
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was an exploratory analysis, p-values of ≤ 0.1
were considered suggestive of an enhanced
response.
In addition to the formal statistical tests,
we calculated an average enhanced response
for each NL parameter at each time t by sum-
ming the E∆it values at each respective time t
for all subjects and dividing by the number of
subjects i. This is referred to as “average
enhanced response” and represents the aver-
age magnitude of the enhanced response
across all subjects (i.e., the magnitude of the
response that is greater than that expected if
the particulate and allergen responses were
strictly additive). Since the Wilcoxon signed-
ranks test assesses whether the ranks, and not
the mean, of the ∆it values are significantly
different from zero, there may not necessarily
be a direct relationship between the average
enhanced response presented in the tables and
the level of their statistical signiﬁcance.
To further quantify the relative magni-
tude of the enhanced response, we calculated
the percent enhancement for each nasal lavage
parameter at each time t by dividing the aver-
age enhanced response by the average of the
baseline levels of the respective nasal lavage
parameter from sessions A, B, and C. For
instance, if the average enhanced response is
equal to the average baseline level, then a
100% enhanced response occurred. We used
the average baseline level from the three ses-
sions to calculate percent enhancement
because baseline levels in healthy, nonexposed
subjects vary temporally (Hauser et al. 1994).
By averaging the baseline values across the
three sessions, the estimate of a true baseline
will be more precise.
A clean air/no allergen treatment arm was
not included in the present study because sta-
tistically we could test for interaction by com-
paring whether the magnitude of the response
to the two treatments together (i.e., particu-
lates and allergen) exceeded the response to
each treatment alone (i.e., particulates alone
and allergen alone). We made the choice not
to include a clean air/no allergen session a
priori because of funding limits. 
Results
Eight of the twelve subjects recruited com-
pleted the full protocol consisting of three
randomized exposure-challenge sessions. One
subject completed only two sessions, two sub-
jects completed one session, and one subject
withdrew before completing any sessions.
Subjects did not complete all three sessions
because of self-reported upper-respiratory-
tract illnesses (i.e., ﬂu) that precluded further
testing during the study period.
Eight nonsmoking subjects, 23–39 years
old, contributed data to the analysis. There
were four male subjects (two were allergic to
ragweed and two were nonatopic) and four
female subjects (three were allergic to red
oak and one was nonatopic); five subjects
were atopic and three were nonatopic.
Demographic data are presented in Table 1.
Of the eight subjects, six did not report
nasal, ocular, or respiratory symptoms after
any of the exposure challenge protocols.
Therefore, analysis of symptom data was
uninformative.
The mean (SD) ROFA concentration
delivered in the particulate exposure session
was 0.96 (0.20) mg/m3; the target concentra-
tion was 1.00 mg/m3. The mass median
diameter of the particles was 1.55 ± 0.44 µm
with σG, a measure of particle size distribu-
tion, of 1.52 ± 0.12. The value of σG indi-
cates that a polydisperse particle distribution
was generated. The average number of deliv-
ered pollen grains/cc air was 7.23 ± 11.32 for
ragweed and 0.58 ± 0.62 pollen grains/cc air
for red oak.
At all time points after allergen challenge,
there was a greater-than-additive response for
total leukocytes, neutrophils, and macrophages
per milliliter when particulates and allergen
were given sequentially as compared to when
each was given alone (Table 2). We found
few eosinophils in the NL fluid, precluding
statistical analysis. The average enhanced
response for total leukocytes and neutrophils
per milliliter were maximal immediately after
allergen challenge and decreased over time.
Immediately after challenge, total leukocytes
per milliliter were enhanced by 143%. For
neutrophils and macrophages per milliliter,
the response immediately after challenge was
significantly enhanced by 130 and 211%,
respectively.
In addition to the enhanced cellular
response, there was a greater-than-additive
response in IL-4 and IL-8 at all time points
after allergen challenge when particulates and
allergen were given sequentially as compared to
when each was given alone (Table 2). The
enhanced response for IL-4 was maximal
immediately after challenge and decreased over
time to a minimum at 42 hr after allergen chal-
lenge. Immediately after and 4 hr after allergen
challenge, the IL-4 response was enhanced by
395 and 410%, respectively. In contrast, the
IL-8 response remained enhanced throughout
the postchallenge period. For IL-8, the
response immediately after and 4 hr after aller-
gen challenge was enhanced 130 and 132%,
respectively.
Although the number of atopic and
nonatopic subjects was small (five and three
subjects, respectively), there were marked dif-
ferences in inflammatory response based on
atopic status. For IL-4, the enhanced response
for the ﬁve atopic subjects (Table 3) was 5- to
10-fold higher than for the three nonatopics
and demonstrated a similar decreasing pattern
as that observed for all subjects as a group. In
atopics, the IL-4 response for immediately
after and 4 and 18 hr after allergen response
was enhanced by 370, 363, and 204%,
respectively. For the three nonatopics, the
IL-4 responses for immediately after and 4
and 18 hr after allergen response were not sig-
nificantly different from zero (0.38 pg/mL,
0.68 pg/mL, and –0.34 pg/mL, respectively).
For IL-8, the average enhanced response
for atopics remained elevated at all time
points after allergen challenge. In atopic sub-
jects, the IL-8 response for immediately after
and 4 and 18 hr after allergen response was
enhanced by 84, 101, and 90%, respectively.
Unexpectedly, in nonatopics, the IL-8
response immediately after allergen challenge
was larger than in atopics, though it was not
significant due to the small sample size. In
nonatopic subjects, the IL-8 response for
immediately after and 4 and 18 hr after aller-
gen response was enhanced by 162, 153, and
90%, respectively.
The stratified analysis for the inflamma-
tory cell counts also showed marked differ-
ences based on atopic status. The average
enhanced response for atopics was signiﬁcant
for total leukocytes and neutrophils per milli-
liter immediately after challenge and was of
borderline signiﬁcance 4 and 18 hr after aller-
gen challenge (Table 3). Leukocytes per milli-
liter were enhanced by 291, 216, and 313%,
respectively, and neutrophils per milliliter
were enhanced by 285, 193, and 323%,
respectively. Interestingly, total leukocytes and
neutrophils per milliliter did not decrease over
time as observed for all subjects as a group,
but remained elevated or increased at 42 hr
after allergen. Macrophages per milliliter were
enhanced by 237, 129, and 234% immedi-
ately after and 4 and 18 hr after allergen chal-
lenge, respectively. For the nonatopic subjects,
at all time points the average enhanced
response for inﬂammatory cells were not sta-
tistically different from zero and were of
smaller magnitude than for the atopic subjects
(data not shown).
We did not see an enhancement in IL-3,
TNF-α, or total IgE in the group of subjects as
a whole or within strata of atopics and
nonatopics. The average enhanced responses
were not signiﬁcantly different from zero (data
not shown). Furthermore, because most of the
NLs had nondetectable levels of tryptase, ECP,
albumin, IL-5, IL-13, MCP-1, and GM-CSF,
we were unable to perform meaningful statistical
analyses on these markers.
Discussion
The present study provides evidence of a
greater-than-additive interaction between
particulate exposure and allergen challenge.
Speciﬁcally, a 1-hr residual oil ﬂy ash particu-
late exposure 3 hr before challenge with
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response. The enhanced nasal response
consisted of an increase in inflammatory 
cells (total leukocytes, neutrophils, and
macrophages increased, but eosinophils did
not) and in cytokines IL-4 and IL-8. The
inflammatory cell influx and cytokine
response differed by atopic status. Atopics had
an enhanced IL-4 and inflammatory cell
response, but nonatopics did not. However,
for IL-8 there was an enhanced response in
both atopics and nonatopics, though it was
larger in nonatopics. The cellular and
cytokine responses showed different time
courses. The enhanced inflammatory cell
response was present immediately after aller-
gen challenge and remained present for 42 hr
after challenge, whereas the IL-4 response was
maximal immediately after allergen challenge
but diminished by 18 hr after allergen.
Although the subjects in our study did not
report clinical symptoms, the observed
enhanced inflammatory response may have
clinical relevance because the ROFA and
pollen exposures were brief, and individuals
are chronically exposed to allergens and to air-
borne particulates in their everyday lives.
IL-4, produced by T cells and mast cells,
contributes to allergic inﬂammation (Brown and
Hural 1997; Ryan 1997) by a variety of mecha-
nisms. Among other functions, it induces IgE
production by B-lymphocytes, promotes differ-
entiation of immature lymphocytes, and inhibits
Th1 responses (Brown and Hural 1997; Ryan
1997). The increased levels of soluble IL-4 may
reﬂect mast cell activation by particulate expo-
sure and may represent one mechanism by
which particulates enhance the allergic response.
IL-8 is a chemokine that recruits neutrophils
(Mukaida et al. 1998; Teran et al. 1996, 1997)
and is produced by a number of cell types
including macrophages and epithelial cells. The
increased levels measured in the present study
most likely contributed to the observed
enhanced neutrophil response.
In the present study, because only the
number of neutrophils, but not eosinophils,
were enhanced, this suggests that the enhanced
cellular response may be an irritant response
rather than an allergic response. In addition,
only IL-4 (aTh2-type cytokine) was elevated,
and no other Th2-type cytokines or other
parameters associated with allergic airway
responses were enhanced. Therefore, the
enhanced response observed may represent an
enhanced irritant response rather than an
allergic response.
One of the strengths of the present study
was that several factors were controlled in the
design. Because exposure-challenge sessions
were randomized, at least 2 weeks apart, and
performed at the same time of day within a
subject, carryover effects and diurnal variabil-
ity were minimized. Furthermore, although
we did not measure the subjects’ exposures to
ambient pollutants, the magnitude of this
exposure relative to the particulate exposure
was low. In addition, since ambient exposure
to ragweed or red oak pollen during the win-
ter months in Boston, Massachusetts, is
unlikely, confounding by ambient allergens is
also unlikely.
By design we chose to elicit only a mini-
mal allergic response because it would be dif-
ficult to detect enhancement of a full
immediate response. If we had elicited a max-
imal or near-maximal immediate response,
any enhancement by particulate exposure
would have been obscured. In addition, a
minimal response was expected because the
subjects were tested out of allergy season and
were not primed at the time of challenge
because it had been several months since they
were last exposed to these allergens.
Therefore, as expected, most subjects did not
report upper-respiratory-tract symptoms in
response to allergen. Further evidence of a
minimal allergic response was that we were
unable to detect changes in tryptase, ECP,
and eosinophils. This conﬁrmed that the size
of our dose was appropriately small because it
did not elicit a full, immediate-phase
response. If a full, immediate-phase response
was elicited by the allergen alone, our power
to detect an enhancement of this response by
particulates would be minimal.
We chose to study red oak and ragweed
pollen because they are two important air-
borne allergens causing allergic rhinitis and
asthma. Although the symptom response was
minimal in the present study, particulate air
pollution may contribute significantly to
increased symptoms in individuals with sea-
sonal allergies because in the ambient envi-
ronment individuals are chronically exposed
to these allergens and to airborne particulates.
The chronicity of exposure may result in
magniﬁed responses as compared to the brief
1-hr exposure to particulates in this study.
We used ROFA, a component of ambient
particulates, rather than collecting ambient
PM10 (PM ≤ 10 µm in diameter). We made
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Table 1. Study subject demographics.
Subject Age Sex Atopic status Allergens with positive skin prick test
12 8 Female Atopic  Red oak, grass mix, mitea
23 9Male Atopic Ragweedb
33 8Male Nonatopic N/A
4 27 Male Nonatopic N/A
53 0 Female Nonatopic N/A
62 3Male Atopic Ragweedb
73 0 Female  Atopic  Red oak, mitea
83 2 Female Atopic  Red oak, grass mix, mite,a
ragweed,b birchc
aDermatophagoides pteronsyssinus. bMixture of short and giant ragweed. cWhite birch.
Table 2. Average enhanced response for nasal lavage parameters immediately after (IA) and 4, 18, and
42 hr after allergen challenge (all subjects, n = 8).a
Average enhanced response at time t
NL parameter Baselineb IA 4 hr 18 hr 42 hr
Inﬂammatory cells
Leukocytes/mL 15,200 21,700* 14,900 19,200 1,900 
Neutrophils/mL 13,900 18,000* 11,700  17,200  900 
Macrophages/mL 900 1,900** 1,600** 1,800  600
Cytokines
IL-4 (pg/mL) 0.55 2.2** 2.2** 0.99 0.81
IL-8 (pg/mL) 220 422** 427** 294 458*
aSee text for explanation of average enhanced response. bAverage baseline value from sessions A, B, and C. *p < 0.1;
**p < 0.05 using Wilcoxon signed-ranks test.
Table 3. Average enhanced response for nasal lavage parameters immediately after (IA) and 4, 18, and 42
hr after allergen challenge (atopic subjects, n = 5).a
Average enhanced response at time t
NL parameter Baselineb IA 4 hr 18 hr 42 hr
Inﬂammatory cells
Leukocytes/mL 10,200 29,700** 22,000* 32,000* 44,100
Neutrophils/mL 8,900 25,400** 17,100  28,700**  42,300
Macrophages/mL 900 2,200 1,200 2,200 –100
Cytokines
IL-4 (pg/mL) 0.88 3.23* 3.18* 1.79* 1.63
IL-8 (pg/mL) 213 179* 215 191 172
aSee text for explanation of average enhanced response. bAverage baseline value from sessions A, B, and C. *p < 0.1;
**p < 0.05 using Wilcoxon signed-ranks test.this choice because we needed a source of
particles that was sufficiently large to allow
us to use the same particle source for all
exposure sessions (16 particulate exposure
sessions). The use of ROFA allowed us to
standardize the composition of particles
delivered across sessions within subjects and
across sessions between subjects. We chose a
high target concentration of ROFA (1
mg/m3) because the subjects were only
exposed to ROFA for 1 hr at rest.
One of the limitations of the present
study was the small sample size, which limited
the power of the study to detect statistically
significant associations. Although there were
only 8 subjects, the data consisted of a total of
24 exposure-challenge sessions, 3 per subject.
Subjects were used as their own control,
increasing study power given a limited num-
ber of subjects, and minimizing confounding
by time-invariant individual characteristics.
Because this was an experimental crossover
study, we were able to tightly control the
experimental conditions, minimizing random
variability that can contribute to diluted mea-
sures of association. This improved our ability
to detect an enhanced response after particu-
late exposure as compared to clean air expo-
sure. However, despite the advantages of
using an experimental crossover study, the
small sample size did limit our ability to
report the enhanced responses as being statis-
tically significant, even though they were of
moderate magnitude, generally greater than a
100% enhancement. We had less power to
determine whether the enhanced allergic
response differed by atopic status. However,
despite the small sample size and limited
power, we found a difference in response
based on atopic status. Although our data are
suggestive of a particulate enhanced response
and a modification of response based on
atopic status, these results need to be con-
firmed because they are based on a limited
number of subjects.
Because of difﬁculties with aerosolization
and standardization, the placebo challenge
did not consist of particles of similar size and
consistency to pollen. However, self-reports
indicate that the subjects were not aware of
whether they were receiving pollen or placebo
challenge. More important, because subjects
were used as their own controls, the use of
room air as a placebo could not account for
the observed enhanced responses. In addition,
we did not have a clean air/no-allergen chal-
lenge session (i.e., a treatment arm without
particulates and without allergen). A clean
air/no-allergen challenge session was not nec-
essary to detect enhancement. It was statisti-
cally appropriate to compare the session with
particulates and allergen together with the ses-
sions with allergen alone and with particulates
alone.
Despite the difﬁculties we encountered in
aerosolizing whole pollen grains, we chose to
use whole pollen grains because they more
closely approximate real-life exposure than
does allergen extract. The major difﬁculty in
aerosolizing whole pollen grains resulted from
the large size of the pollen grains (i.e., > 10
mm) and their stickiness. These characteris-
tics produced random between-session vari-
ability, which was larger for ragweed than for
red oak. The random between-session vari-
ability would tend to bias results toward the
null hypothesis, making it more difficult to
detect enhanced responses.
To date, most of the human studies inves-
tigating whether ambient pollution enhances
the allergic response have used gaseous pollu-
tants. In general, these studies have found an
enhanced allergic response of asthmatics to
allergen after exposure to ozone, nitrogen
dioxide, and a combination of nitrogen diox-
ide and sulfur dioxide (Jorres et al. 1996;
Rusznak et al. 1996; Strand et al. 1998;
Tunnicliffe et al. 2001). Tunnicliffe and col-
leagues (2001) studied the effect of a 1-hr
exposure to nitrogen dioxide (100 or 400
ppb) on airway responses to inhaled allergen
in eight asthmatic subjects. They found sig-
niﬁcant differences between air and 400 ppb
NO2 on the early asthmatic response (maxi-
mum percent change in forced expiratory vol-
ume in 1 sec [FEV1] during the ﬁrst 2 hr after
challenge) and the late asthmatic response
(maximum percent change in FEV1) to
inhaled allergen. Strand and co-workers
(1997) studied 18 subjects with asthma and
allergy to pollen. Subjects were exposed to
low-level NO2 (490 mg/m3) for 30 min, fol-
lowed 4 hr later by allergen inhalation chal-
lenge with standardized and freeze-dried
allergen extracts. They found an enhancement
of the asthmatic reaction during the late
phase by NO2 exposure, and peak expiratory
flow after allergen challenge was on average
6.6% lower after NO2 as compared to air
exposure. However, they did not ﬁnd changes
in serum eosinophil numbers nor eosinophil
cationic protein levels. As in our study, they
delivered the pollutant several hours before
allergen challenge because of earlier work sug-
gesting a delayed response to the pollutant.
There are limited experimental human
studies investigating whether particulates
enhance the allergic response. Takenaka and
co-workers (1995) found that an extract of
polyaromatic hydrocarbons from diesel
exhaust particulates enhanced human IgE
production from B-cells derived from both
nonallergic and allergic individuals. Diaz-
Sanchez and co-workers (1997) investigated
combined diesel exhaust particulate and rag-
weed allergen challenge on nasal humoral
immune responses in 13 ragweed-sensitive
subjects. Subjects were challenged with the
short ragweed allergen Amb a I. As compared
with challenge with ragweed alone, challenge
with diesel exhaust particulates and ragweed
induced higher ragweed-speciﬁc IgE, but not
total IgE, in nasal washes 1 and 4 days after
challenge. In addition, challenge with diesel
and ragweed resulted in decreased or no
change in mRNA expression for Th 1-type
cytokines (interferon-γ and IL-2), but ele-
vated mRNA expression for Th 2-type
cytokines (IL-4, -5, -6, -10, -13). Subjects did
not report a significant increase in symptom
severity scores after challenge with diesel
exhaust particulates and ragweed allergen, as
compared to challenge with ragweed alone.
In a recent study on 10 atopic asthmatic
adults, particulate sulfuric acid exposure
potentiated early asthmatic response to grass
pollen allergen (Tunnicliffe et al. 2001).
Subjects were exposed to sulfuric acid particu-
lates at concentrations of 0.1 and 1.0 mg/m3
for 1 hr. Fourteen hours after exposure sub-
jects underwent a ﬁxed-dose allergen challenge
with grass pollen allergen. The early asthmatic
response was defined as the maximum per-
centage change in FEV1 during the ﬁrst 2 hr
after allergen challenge. The difference
between the 1 mg/m3 sulfuric acid exposure
and air was –4.3% [95% conﬁdence interval
(CI), –1.2 to –7.4), and the 0.1 mg/m3 sulfu-
ric acid exposure and air difference was –2.6%
(95% CI, 0.0 to –5.3).
There are several potential mechanisms by
which particulates may produce an enhanced
allergic response. It is possible that the ROFA-
induced inflammation (Hauser et al. 1995)
leads to vasodilation and greater absorption of
the allergen and therefore a greater allergic
response. Another possible mechanism is that
the ROFA could induce an increase in nasal
cytokine production, which leads to an
enhanced allergen response. Evidence for this
possible mechanism comes from a study by
Diaz-Sanchez and co-workers (1996) on
enhanced nasal cytokine production in
humans after in vivo nasal exposure to 0.3 mg
of diesel exhaust particles in 200 µl saline.
They found an increase in cytokine mRNAs
for IL-2, IL-4, IL-5, IL-6, IL-10, and IL-13
and interferon-γ after challenge with diesel par-
ticulates. The nonspeciﬁc increase in cytokine
expression was not simply the result of an
increase in T-cells recovered in lavage fluid.
The enhanced cytokine expression by diesel
exhaust exposure may contribute to enhanced
local IgE production. Evidence supporting this
comes from earlier studies by the same research
group that showed enhanced human IgE pro-
duction both in vivo and of purified B-cells
after exposure to the aromatic hydrocarbons
from diesel exhaust (Diaz-Sanchez et al. 1994;
Takenaka et al. 1995). The increased IgE pro-
duction may increase the likelihood of allergic
symptoms. In summary, the diesel exhaust
Articles | Hauser et al.
476 VOLUME 111 | NUMBER 4 | April 2003 • Environmental Health PerspectivesArticles | Particle-enhanced allergic response
Environmental Health Perspectives • VOLUME 111 | NUMBER 4 | April 2003 477
studies suggest a possible mechanism that may
be relevant to ROFA.
In the present study, there was evidence of
a greater-than-additive interaction between
particulate exposure and allergen challenge.
The particulates used were ROFA, a compo-
nent of air pollution. The ROFA used in the
present study consisted of a complex mixture
that contained transition metals, including
vanadium, nickel, and iron. It is unclear
whether the enhanced response we observed
was speciﬁc to ROFA or whether it would be
caused by any particle, such as inert particu-
lates. Further research is needed to investigate
which constituents of the ROFA are responsi-
ble for the enhanced allergic response.
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